Jayson Donald Alexander Dallas

CIK 1650322 · President and CEO · last filed 2025-06-20

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$580.3K

Companies

4

Total Filings

36

Lifetime Open-Market Net

-$122.0K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Damora Therapeutics, Inc. (GLTO) Delisted Director $28.69 $0 6 2025-06-20
ARENA PHARMACEUTICALS INC (ARNA) Delisted Director 0 $99.99 $0 -$272.5K 10 2022-03-11
COLL President and CEO 0 $34.64 $0 $150.5K 10 2020-10-14
RARE EVP & Chief Commercial Officer 23,830 $24.35 $580.3K $0 10 2018-06-04

Recent Filings · Page 4 of 4

36 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2017-03-01 RARE Grant (A) +4,500 $0 EDGAR
2017-02-14 ARENA PHARMACEUTICALS INC (ARNA) Delisted Grant (A) $0 EDGAR
2016-08-08 RARE Tax (F) −940 -$60.4K EDGAR
2016-06-07 RARE Grant (A) $0 EDGAR
2016-06-03 RARE Grant (A) +3,400 $0 EDGAR
2015-08-06 RARE Grant (A) +10,000 $0 EDGAR
Showing 3136 of 36
Page 4 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.